Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The side effects some potentially fatal reported by the Medicines and Healthcare Products Regulatory Agency (MHRA) and news reports across the west, highlighting how patients regain weight when they are no longer taking GLP-1s, could mean many Chinese patients will be anxious about taking these drugs
However, that is not the reality: even diabetic patients treated with GLP-1 RAs are more likely to stop them than other second-line anti-diabetic medicines
GLP-1 receptor agonists are a class of medications that mimic the glucagon-like peptide-1 hormone, enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying to lower blood glucose levels
How to Take Retatrutide Retatrutide is expected to be given once weekly as a subcutaneous injection into the abdomen, thigh or upper arm
